These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. Comprehensive Echocardiographic and Cardiac Magnetic Resonance Evaluation Differentiates Among Heart Failure With Preserved Ejection Fraction Patients, Hypertensive Patients, and Healthy Control Subjects. Mordi IR, Singh S, Rudd A, Srinivasan J, Frenneaux M, Tzemos N, Dawson DK. JACC Cardiovasc Imaging; 2018 Apr; 11(4):577-585. PubMed ID: 28823736 [Abstract] [Full Text] [Related]
25. Impact of T2DM on right ventricular systolic dysfunction and interventricular interactions in patients with essential hypertension: evaluation using CMR tissue tracking. Li XM, Yan WF, Jiang L, Shi K, Ren Y, Han PL, Peng LQ, Guo YK, Yang ZG. Cardiovasc Diabetol; 2022 Nov 09; 21(1):238. PubMed ID: 36352469 [Abstract] [Full Text] [Related]
26. The Combination of Feature Tracking and Late Gadolinium Enhancement for Identification Between Hypertrophic Cardiomyopathy and Hypertensive Heart Disease. Liu S, Li Y, Zhao Y, Wang X, Wu Z, Gu X, Xu B, Li Y, Tian J, Cui J, Wang G, Yu B. Front Cardiovasc Med; 2022 Nov 09; 9():865615. PubMed ID: 35647085 [Abstract] [Full Text] [Related]
30. The diagnostic value of multiparameter cardiovascular magnetic resonance for early detection of light-chain amyloidosis from hypertrophic cardiomyopathy patients. Yue X, Yang L, Wang R, Chan Q, Yang Y, Wu X, Ruan X, Zhang Z, Wei Y, Wang F. Front Cardiovasc Med; 2022 Nov 09; 9():1017097. PubMed ID: 36330005 [Abstract] [Full Text] [Related]
32. Additive effects of mitral regurgitation on left ventricular strain in essential hypertensive patients as evaluated by cardiac magnetic resonance feature tracking. Tang SS, Shi R, Zhang Y, Li Y, Li XM, Yan WF, Jiang L, Yang ZG. Front Cardiovasc Med; 2022 Nov 09; 9():995366. PubMed ID: 36440008 [Abstract] [Full Text] [Related]
36. Evaluation of systolic and diastolic properties of hypertensive heart failure using speckle-tracking echocardiography with high volume rates. Minatoguchi S, Kawasaki M, Tanaka R, Yoshizane T, Ono K, Saeki M, Nagaya M, Sato H, Nishigaki K, Noda T, Zile MR, Minatoguchi S. Heart Vessels; 2017 Oct 09; 32(10):1202-1213. PubMed ID: 28638961 [Abstract] [Full Text] [Related]
37. Electrocardiogram-less, free-breathing myocardial extracellular volume fraction mapping in small animals at high heart rates using motion-resolved cardiovascular magnetic reesonance multitasking: a feasibility study in a heart failure with preserved ejection fraction rat model. Han P, Zhang R, Wagner S, Xie Y, Cingolani E, Marban E, Christodoulou AG, Li D. J Cardiovasc Magn Reson; 2021 Feb 11; 23(1):8. PubMed ID: 33568177 [Abstract] [Full Text] [Related]
38. Left Atrial and Ventricular Strain Differentiates Cardiac Amyloidosis and Hypertensive Heart Disease: A Cardiac MR Feature Tracking Study. Zhang X, Zhao R, Deng W, Li Y, An S, Qian Y, Liu B, Yu Y, Li X. Acad Radiol; 2023 Nov 11; 30(11):2521-2532. PubMed ID: 36925334 [Abstract] [Full Text] [Related]
40. Long-term outcomes prediction in diabetic heart failure with preserved ejection fraction by cardiac MRI. Yang W, Zhu L, He J, Wu W, Zhang Y, Zhuang B, Xu J, Zhou D, Wang Y, Liu G, Sun X, Zhang Q, Sirajuddin A, Arai AE, Zhao S, Lu M. Eur Radiol; 2024 Sep 11; 34(9):5678-5690. PubMed ID: 38421414 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]